MedTrace Logo

TRIO CTO (Taiwan Research Initiative on Coronary Total Occlusion)

NCT06917378 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2025-12-18

No results posted yet for this study

Summary

Coronary chronic total occlusions (CTO) present a significant challenge in the field of interventional cardiology. These complex lesions, characterized by complete blockage of a coronary artery for a prolonged duration, often require specialized techniques and strategies to achieve successful revascularization.

Conditions

  • Chronic Total Occlusion (CTO)

Interventions

PROCEDURE

Percutaneous coronary intervention of coronary chronic total occlusion

Coronary CTO was identified by coronary angiography, and its revascularization was attempted by either antegrade, retrograde or both approach.

Sponsors & Collaborators

  • Chang Gung Memorial Hospital

    collaborator OTHER

  • Taipei Veterans General Hospital, Taiwan

    collaborator OTHER_GOV

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Hsien-Li Kao, MD · National Taiwan University Hospital

Eligibility

Min Age
20 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2034-12-31
Completion
2034-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06917378 on ClinicalTrials.gov